Fulton Bank, N.A. Biogen Inc. Transaction History

Fulton Bank, N.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 03, 2020	SELL	$268.85 - $341.04 $281,754 - $357,409	-1,048 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $80,541 - $111,289	-366 Reduced 25.88%	1,048 $311,000
Q3 2019 Oct 03, 2019	BUY	$217.44 - $243.88 $46,749 - $52,434	215 Added 17.93%	1,414 $329,000
Q2 2019 Jul 03, 2019	BUY	$219.29 - $241.72 $10,306 - $11,360	47 Added 4.08%	1,199 $281,000
Q1 2019 Apr 03, 2019	SELL	$216.71 - $338.96 $13,652 - $21,354	-63 Reduced 5.19%	1,152 $272,000
Q4 2018 Jan 03, 2019	SELL	$278.5 - $352.75 $408,002 - $516,778	-1,465 Reduced 54.66%	1,215 $366,000
Q3 2018 Oct 03, 2018	BUY	$293.51 - $383.83 $3,522 - $4,605	12 Added 0.45%	2,680 $947,000
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $90,389 - $107,725	351 Added 15.15%	2,668 $775,000
Q1 2018 May 02, 2018	BUY	$260.13 - $367.91 $195,617 - $276,668	752 Added 48.05%	2,317 $634,000
Q4 2017 Jan 04, 2018	BUY	$307.64 - $344.58 $41,839 - $46,862	136 Added 9.52%	1,565 $498,000
Q3 2017 Oct 04, 2017	BUY	$281.15 - $329.69 $401,763 - $471,127	1,429	1,429 $447,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.